Hepatic Tumours

  • Matteo Carella
  • Riccardo Masetti
  • Claudio Antonellini
  • Beatrice Randi
  • Andrea PessionEmail author


Liver tumours account for only 5% of all tumours in prenatal and neonatal period [1]. They include a variety of benign and malignant neoplasms with a different distribution than in older children (Table 37.1). The most common are vascular neoplasm, of which infantile haemangioendothelioma and cavernous haemangioma are the most frequently types, and embryonal hepatic cell tumours such as hepatoblastoma. Mesenchymal hamartomas and germ cell tumours can occur very rarely, and the differential diagnosis of these tumours could be very difficult.


  1. 1.
    Makin E, Davenport M. Fetal and neonatal liver tumours. Early Hum Dev. 2010;86:637–42.CrossRefGoogle Scholar
  2. 2.
    von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8:403–10.CrossRefGoogle Scholar
  3. 3.
    Prokurat A, Chrupek M, Ko-ciesza A, et al. Hemangioma of the liver in children-conservative versus operative treatment. Surg Child Intern. 2000;3:202–7.Google Scholar
  4. 4.
    Deb G, Donfrancesco A, Ilari I, et al. Hemangioendothelioma: Successful therapy with interferon-α. A study in association with the Italian Pediatric Haematology/Oncology Society (AIEOP). Med Pediatr Oncol. 2002;38:118–9.CrossRefGoogle Scholar
  5. 5.
    Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216–21.CrossRefGoogle Scholar
  6. 6.
    Czauderna P, Lopez-Terrada D, Hiyama E, Haberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr. 2014;26:19–28.CrossRefGoogle Scholar
  7. 7.
    Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: A trend or a chance? J Pediatr. 1997;130:557–60.CrossRefGoogle Scholar
  8. 8.
    Aronson DC, Meyers RL. Malignant tumors of the liver in children. Semin Pediatr Surg. 2016;25:265–75.CrossRefGoogle Scholar
  9. 9.
    Ammann RA, Plaschkes J, Leibundgut K. Congenital hepatoblastoma: A distinct entity? Med Pediatr Oncol. 1999;32:466–8.CrossRefGoogle Scholar
  10. 10.
    Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37:123–32; quiz 249–50.CrossRefGoogle Scholar
  11. 11.
    Aronson DC, Czauderna P, Maibach R, Perilongo G, Morland B. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg. 2014;19:201–7.CrossRefGoogle Scholar
  12. 12.
    De Ioris M, Brugieres L, Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44:545–50.CrossRefGoogle Scholar
  13. 13.
    Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, Gore L, Feusner JH. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer. 2009;52:328–34.CrossRefGoogle Scholar
  14. 14.
    Hiyama E. Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr. 2014;3:293–9.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Hishiki T, Matsunaga T, Sasaki F, et al. Outcome of hepatoblastomas treated using the Japanese study group for pediatric liver tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int. 2011;27:1–8.CrossRefGoogle Scholar
  16. 16.
    Zsiros J, Brugieres L, Brock P, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;14:834–42.CrossRefGoogle Scholar
  17. 17.
    Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, et al. Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer. 2013;60:1817–25.CrossRefGoogle Scholar
  18. 18.
    Isaacs H Jr. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42:1797–803.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Matteo Carella
    • 1
  • Riccardo Masetti
    • 1
  • Claudio Antonellini
    • 2
  • Beatrice Randi
    • 2
  • Andrea Pession
    • 1
    Email author
  1. 1.Department of Pediatric Hematology OncologySant’Orsola-Malpighi University HospitalBolognaItaly
  2. 2.Department of Pediatric SurgerySant’Orsola-Malpighi University HospitalBolognaItaly

Personalised recommendations